Please login to the form below

I have forgotten my password

Daniel O'Day

This page shows the latest Daniel O'Day news and features for those working in and with pharma, biotech and healthcare.

Gilead’s COVID-19 drug Veklury brought in almost $2bn in Q4

treated with the drug, according to Gilead's chief executive officer Daniel O’Day.

Latest news

Gilead set to acquire hepatitis specialist MYR for €1.15bn

HDV is a devastating disease with high unmet medical need. With Hepcludex we have the opportunity to address that need with a first-in-class therapy,” said Daniel O’Day, chairman
Galapagos mid-stage trial failure raises concerns for Gilead deal

Daniel O’Day, even further into question.
Gilead agrees $21bn buyout of Immunomedics

This acquisition represents significant progress in Gilead’s work to build a strong and diverse oncology portfolio,” said Daniel O’Day, chairman and chief executive officer of Gilead.
Gilead makes a play for novel cancer drug with Tizona deal

Tizona is pursuing first-in-class cancer immunotherapies that could make an important difference in oncology by helping patients who don’t respond to current checkpoint inhibitors,” said Daniel O’Day,
Gilead and Arcus complete closing of ten-year immunotherapy partnership

Gilead is committed to accessing the world’s best innovation in immuno-oncology and our agreement with Arcus further demonstrates that commitment,” said Daniel O’Day, chairman and chief executive officer, ... Gilead has been expanding into

More from news
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest Intelligence

As COVID-19 takes over the world, biopharma fights back

A number of clinical trials evaluating remdesivir’s efficacy in COVID-19 are currently underway in China and the US, with Gilead CEO Daniel O’Day commenting that “initial data” is ... have activity for,” added O’Day.
20 for 2020 – Five pharma leaders to watch in 2020

The pipeline-building deal is the largest under new Gilead chief executive Daniel O’Day, who took the helm of Gilead in March 2019, and includes a massive $3.95bn upfront,
The rise of real-world evidence

Having been stung by drugs that shine in RCTs but under deliver in day-to-day practice, these stakeholders want to know what effect therapies will have on people in the ... The takeover was driven by a belief that “regulatory-grade real-world evidence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Ex-Roche CMO Sandra Horning joins Gilead’s board of directors

We are very pleased to welcome Sandra Horning to our Board of Directors,” said Daniel O’Day (pictured right), chairman and chief executive officer of Gilead Sciences.
AstraZeneca hires Roche’s Pascal Soriot as CEO

At Roche, Daniel O'Day, currently chief operating officer Roche Diagnostics has been appointed as Soriot's replacement as chief operating officer of Roche Pharma effective September 1, 2012. ... O'Day will be succeeded by Roland Diggelmann, currently

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Associate Account Director: Competitive Salary

Senior Medical Writer: Competitive Salary

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Senior Content Editor - Biotechnology: Salary TBC

Account Manager: Competitive Salary

Senior Account Executive: Competitive Salary

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Medical Editor: Competitive Salary

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

No results were found

PMHub

Add my company

AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Empowering patients empowers results: Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials: What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training: Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...